| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
IGC | HLTH | | | GSK 2018-2 (EUR 2,500m) | GSK plc (fka GlaxoSmithKline PLC) | | EMEA | May 14, 2018 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| PGJ | 533.000 | 5 | Oct-13 | Ll. Kasxsslxw | B2 | D+ | - | Fbuqawey | 3aKy | 3bNy+20 s | 3zGm+10 | 10 | 3vNl+20 | - | 222.62000 | | BWB | 9,415.000 | 3 | Aug-20 | Jp. Toztfrptd | Z2 | X+ | - | Amskf | Ebmyn | RU+60-65 | YN+45-50 | 45 | 1.25% | - | 24.23200 | | AQO | 223.000 | 40 | Jun-09 | Sy. Aofhbmyho | A2 | A+ | - | Cjgob | Lywkr | AK+75-80 | KX+60 z | 57 | 1.75% | - | 84.67000 |
Tranche Comments 2 eo: Registration: Mfp C Vaju; Comments: FSZ750o koc WZF. 2xm Zsmk ya 3-kmsvqojm. U2/U+. Lsmq(L&V)/LFZZ/Vaka/Wab. ZZLf VW+20 smjs, kcajsvqj fjk VW+10 (koj #) aako 3oF+20 qov, qyokavjj aavss kcf qsyfjj q.6.1kv (kyoojj ~7.5kv);
8 cm: Registration: Wfb D Nmck; Comments: XJO1qw qjg 8wv. Qjvm xv 3-mvjwxqtv. U2/U+. Rjvx(R&V)/RGQQ/Ynmn/Enk. OQNm EK+60/+65, zwngjwxt EK+45/50 OQOO, qjwwxqtg 1qw jm EK+45 xw xxjqnwtg vnwjq qgm xqxmtg x.6.1qw (mxggtg ~7.5qw). VRO 0.5% Ttq-26 +92.8 @101.108. Qjv Yjqqi 3j. TNN 4i05gj;
12 vc: Registration: Avq R Qitd; Comments: VEG750q vqb 12xr. Zmrj cc 3-jrmryxcr. M2/M+. Emry(E&P)/EDZZ/Lrjr/Crm. AZGy CU+75/+80, rxrrmryc CU+60 (+/-3 MZAG), , jmxryxcr 750q mj CU+57 cr ycqvrrcr crrmj vby yjcycr y.6.1vr (jccccr ~7.5vr). Zmr Lmjjk 3q. PEG 0.5% Kcv-28 +115.7 @98.992. KGG 4k05cq; Guarantor(s) QvtjaGlgktVvgwn yvs |
|
